Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Decoding Sequence Recognition Code of Nucleic Acid-Binding Proteins of Human-Infecting DNA Viruses

ABSTRACT: We applied an in vitro transcription–reverse transcription (ivTRT)-based ssDNA-SELEX workflow to profile the DNA-binding specificities of putative nucleic acid–binding proteins (NBPs) from ssDNA viruses. Translocated in liposarcoma/fused in sarcoma (TLS/FUS), a protein with well-established ssDNA-binding activity, was included as a positive control.

ORGANISM(S): synthetic construct

PROVIDER: GSE335776 | GEO | 2026/08/13

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Decoding Sequence Recognition Code of Nucleic-Acid Binding Proteins of Human-Infecting DNA Viruses

Project description:We applied high-throughput SELEX (HT-SELEX) to profile the DNA-binding specificity of 106 putative nucleic acid–binding proteins (NBPs) from 103 DNA viruses. Three NBPs derived from viruses whose hosts are not humans (YP_010782993.1, NP_671816.1, and AVM80381.1) were included as negative controls. We identified sequence motifs for 33 proteins.

2026-08-13 | GSE309420 | GEO

Decoding Sequence Recognition Code of Nucleic-Acid Binding Proteins of Human-Infecting DNA Viruses

Project description:Decoding Sequence Recognition Code of Nucleic-Acid Binding Proteins of Human-Infecting DNA Viruses

| PRJNA1336044 | ENA

Decoding Sequence Recognition Code of Nucleic Acid-Binding Proteins of Human-Infecting DNA Viruses

Project description:Decoding Sequence Recognition Code of Nucleic Acid-Binding Proteins of Human-Infecting DNA Viruses

| PRJNA1479426 | ENA

The Chimeric Oncoprotein TLS-CHOP Represses Expression of the Anticancer Cytokine MDA-7/IL-24 in Myxoid Liposarcoma Cells

Project description:The TLS-CHOP fusion protein is found in the majority of human myxoid liposarcomas (MLS), and is thought to have oncogenic functions. Until now, however, the molecular function of TLS-CHOP for oncogenesis is still elusive. In this report, we have revealed that knockdown of TLS-CHOP by specific siRNA in MLS-derived cell lines inhibits cell growth and leads to cell death. Thus, TLS-CHOP may be a promising therapeutic target for MLS treatment. Thus we explored the target genes of TLS-CHOP influence cell-proliferation or cell death with microarray. We compared the whole mRNA profiles of cells treated with TLS-CHOP siRNA or control oligo in two myxoid liposarcoma cell-line.

2013-12-27 | E-GEOD-33616 | biostudies-arrayexpress

unclassified ssDNA viruses

Project description:unclassified ssDNA viruses

| PRJNA16926 | ENA

ssDNA aptamers targeting Salmonella paratyphi A [SELEX]

Project description:ssDNA aptamers targeting Salmonella paratyphi A [SELEX]

| PRJNA564266 | ENA

SELEX and RIP-Seq identification of nucleic acid sequences bound by CIRBP

Project description:SELEX (systematic evolution of ligands by exponential enrichment) and RNA Immunoprecipitation (RIP)-seq revealed that CIRBP directly binds the 3’UTR of Atp5g3.

2021-01-11 | GSE164523 | GEO

The E3 ubiquitin ligase RFWD3 is required for translesion DNA synthesis

Project description:Lesions on DNA can uncouple DNA synthesis from helicase unwinding, generating stretches of unreplicated single stranded DNA (ssDNA) behind the replication fork. These ssDNA gaps need to be filled in to complete DNA duplication and thereby avoid the generation of DNA double-stranded breaks (DSBs), a major source of genomic instability. Gap filling repair involves either translesion DNA synthesis (TLS) or template switching (TS) to bypass the lesion. At the heart of these processes, ubiquitylated PCNA recruits many proteins that dictate pathway choice, but the enzymes regulating PCNA ubiquitylation in vertebrates remain poorly defined. Here we report that the E3 ubiquitin ligase RFWD3 promotes non-specific ubiquitylation of proteins on ssDNA, to enhance protein accumulation and stimulate gap filling repair. The absence of RFWD3 leads to a profound defect in recruitment of key repair and signaling factors to damaged chromatin, including ubiquitin and proteins known to ubiquitylate and interact with ubiquitylated PCNA. As a result, PCNA ubiquitylation is severely inhibited without RFWD3, and TLS across different DNA lesions drastically impaired. We propose that RFWD3 is an essential coordinator of the response to ssDNA gaps, where it triggers wide spread ubiquitylation to drive recruitment of effectors of PCNA ubiquitylation and DNA damage bypass.

2020-12-15 | PXD018217 | Pride

The E3 ubiquitin ligase RFWD3 is required for translesion DNA synthesis (total proteome)

Project description:Lesions on DNA can uncouple DNA synthesis from helicase unwinding, generating stretches of unreplicated single stranded DNA (ssDNA) behind the replication fork. These ssDNA gaps need to be filled in to complete DNA duplication and thereby avoid the generation of DNA double-stranded breaks (DSBs), a major source of genomic instability. Gap filling repair involves either translesion DNA synthesis (TLS) or template switching (TS) to bypass the lesion. At the heart of these processes, ubiquitylated PCNA recruits many proteins that dictate pathway choice, but the enzymes regulating PCNA ubiquitylation in vertebrates remain poorly defined. Here we report that the E3 ubiquitin ligase RFWD3 promotes non-specific ubiquitylation of proteins on ssDNA, to enhance protein accumulation and stimulate gap filling repair. The absence of RFWD3 leads to a profound defect in recruitment of key repair and signaling factors to damaged chromatin, including ubiquitin and proteins known to ubiquitylate and interact with ubiquitylated PCNA. As a result, PCNA ubiquitylation is severely inhibited without RFWD3, and TLS across different DNA lesions drastically impaired. We propose that RFWD3 is an essential coordinator of the response to ssDNA gaps, where it triggers non-specific ubiquitylation to drive recruitment of effectors of PCNA ubiquitylation and DNA damage bypass.

2020-12-15 | PXD021445 | Pride